S. Florida - Track 3

ACO Name and Location

Orange Accountable Care Organization of South Florida, LLC
14750 NW 77th Court, Suite 308, Miami Lakes, FL 33016


ACO Primary Contact

Primary Contact Name Lissette Exposito RN, BSN, MHSA, Founder, President and CEO
Primary Contact Phone Number 786.363.8500
Primary Contact Email Address Lissette.Exposito@orangecaregroup.com

 

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Richard Bobe N
Claire Katz MD N
Luis Velazquez N
Herbert Slavin N
David Vastola, MD N
Leonard Pianko MD N
Luis R. Padron MD PA N
Comprehensive Healthcare Of Miami N
Your Good Health Medical Group PA N
Charles Yanes, M.D., P.A. N
Associates in Family Practice of Broward, LLC N
Bernhard Brijbag MD N
Lewis Semel N
Ageless Medicine Associates Inc. N
Mario Almeida-Suarez N
Luis Padron N
Aurelio Torres PA N
Bobecorp, Inc. N
Primehealth Physicians, LLC N
Claudia V. Perdei Md, P.A. N
Gilbert Medical Group Inc. N
RICARDO O. CALONGE, M.D., P.A. N
Charles Yanes, M.D., P.A. N
Ricardo Calonge N
Marlenny Feliz Cruz N
Luis A Velazquez MD PA N
Mario A. Almeida MD, PA N
The Centre for Internal Medicine P.A. N
Martha M Rodriguez MD PA N
Comprehensive Primary Care N
Bernhard Brijbag N
Personal Physician Care, P.A. N
Leonard J Pianko Md Pa N
Lewis H Semel, MD, PA N
EAST SIDE MEDICAL CENTER OF SOUTH FLORIDA, LLC N
Claudia Perdei MD PA N
Marlon Gilbert N
Aurelio Torres Consuegra N
Milton A. Jimenez MD PA N


ACO governing body:

Member Member’s Voting Power Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Last Name First Name Title/Position
Exposito Lissette President, CEO & Board Chair 9% Board Chair and Voting Member
Cabral, MD Amadeo CSO & Board Member 9% Voting Member
Quintela, MD Pablo Sneior Medical Director & Board Member 9% ACO Participant & Voting Member The Centre for Internal Medicine P.A.
Fernandez, MD Antonio Board Member 9% ACO Participant & Voting Member Comprehensive Primary Care
Pancorbo, MD Dario Board Member 9% ACO Participant & Voting Member Comprehensive Healthcare Of Miami
Calonge, MD Ricardo Board Member 9% ACO Participant & Voting Member Ricardo O. Calonge MD PA
Jimenez, MD Milton Medical Director & Board Member 9% ACO Participant & Voting Member Milton A. Jimenez MD PA
Yanes, MD Charles Board Member 9% ACO Participant & Voting Member Charles Yanes, M.D., P.A.
Gilbert, MD Marlon Board Member 9% ACO Participant & Voting Member Gilbert Medical Group Inc.
Kutner, MD Mark Board Member 9% ACO Participant & Voting Member Primehealth Physicians, LLC
Pujol, MD Isidro Board Member 9% ACO Participant & Voting Member Comprehensive Primary Care
Oliver Mara Board Member 1% ACO Patient and Medicare Beneficiary Representative

 

Key ACO clinical and administrative leadership:

Lissette Exposito ACO Executive
Pablo Quintela Medical Director
Marc Troisi Compliance Officer
Ana Rodriguez, CPC Quality Assurance/Improvement Officer

 

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Quality and Informatics Pablo Quintela, MD, Chair
Patient Experience Raphael Ruiz, Chair
Finance and Contracting Frank Exposito, Co-Chair

Pablo Quintela, MD, Co-Chair

 

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals

 

Shared Savings and Losses

Amount of Shared Savings/Losses

  • N/A

 

Shared Savings Distribution

Proportion invested in infrastructure: 25%
Proportion invested in redesigned care processes/resources: 25%
Proportion of distribution to ACO participants: 50%

Quality Performance Results

2016 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information N/A 80.51
ACO-2 CAHPS: How Well Your Providers Communicate N/A 93.01
ACO-3 CAHPS: Patients’ Rating of Provider N/A 92.25
ACO-4 CAHPS: Access to Specialists N/A 83.49
ACO-5 CAHPS: Health Promotion and Education N/A 60.32
ACO-6 CAHPS: Shared Decision Making N/A 75.40
ACO-7 CAHPS: Health Status/Functional Status N/A 72.30
ACO-34 CAHPS: Stewardship of Patient Resources N/A 26.97
ACO-8 Risk Standardized, All Condition Readmission N/A 14.70
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) N/A 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes N/A 53.20
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure N/A 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions N/A 59.81
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) N/A 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) N/A 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements N/A 82.72
ACO-39 Documentation of Current Medications in the Medical Record N/A 87.54
ACO-13 Falls: Screening for Future Fall Risk N/A 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization N/A 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults N/A 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up N/A 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention N/A 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan N/A 53.63
ACO-19 Colorectal Cancer Screening N/A 61.52
ACO-20 Breast Cancer Screening N/A 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented N/A 76.79
ACO-42 Statin therapy for the Prevention and Treatment of Cardiovascular Disease N/A 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control N/A 18.24
ACO-41 Diabetes: Eye Exam N/A 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure N/A 70.69
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic N/A 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) N/A 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) N/A 79.67

 

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

 

 

Payment Rule Waivers

  • Yes, our ACO does use the SNF 3-Day Rule Waiver.

 

Didn’t find what you’re looking for?
Contact Us with questions, comments, and requests.